← Open Payments lookup

SAMUEL AMOAKO: Open Payments

NPI 1245579879 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,940 in 106 payments from 12 companies in 2025. Trend: 2023 $125 · 2024 $1,027 · 2025 $1,940

Food & beverage: $1,940
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.26$468
Teva Pharmaceuticals USA, Inc.18$341
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$301
ABBVIE INC.10$190
E.R. Squibb & Sons, L.L.C.16$184
Neurocrine BioSciences, Inc.8$150
Alkermes, Inc.5$117
Vanda Pharmaceuticals Inc.2$66
Janssen Pharmaceuticals, Inc3$51
Bausch Health US, LLC2$29

Products named: REXULTI, CAPLYTA, AUSTEDO XR, VRAYLAR, INGREZZA, COBENFY, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.